Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

HYDERABAD, India, Oct. 1, 2025 /PRNewswire/ -- Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-generation sequencing (NGS) technologies closer to patients and healthcare providers across the country.

By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely, accessible, and informative testing in key areas such as reproductive health, cancer screening, and personalized medicine.

Bringing Advanced Genomics into Everyday Practice

AMPATH's nationwide infrastructure—comprising over 20 satellite laboratories and more than 2,000 collection points—provides a strong foundation to introduce genomics into routine diagnostics. Leveraging this reach, the newly established NGS laboratory in Hyderabad will offer:

• triSure NIPT – A comprehensive non-invasive prenatal screening solution that provides insights into chromosomal conditions, microdeletions, and select single-gene disorders, supporting expectant parents with safe, early options for fetal health assessment and maternal well-being.
• SPOT-MAS – An innovative, clinically validated early cancer screening solution, designed to detect signals from 75 cancer types and subtypes using a single blood sample—providing physicians with additional tools to support early intervention.
• K-TRACK, K-4CARE – World-class cancer monitoring & genomic profiling solutions powered by multi-omics, enabling physicians to personalize treatment and monitor recurrence with greater confidence.

Supporting Better Patient Care Through Advanced Testing

The collaboration between Gene Solutions and Ampath introduces advanced diagnostic tools that support more informed clinical decisions. By offering access to innovative genomic solutions, the partnership contributes to:

• Safer, more informative prenatal screening, empowering expectant parents with early, accurate insights into fetal health and maternal conditions.
• Earlier cancer detection, enabling physicians to identify signals from major cancers, including breast, lung, colorectal, and head & neck cancers, through a simple blood test.
• Personalized cancer care, helping oncologists tailor treatment and monitor recurrence through non-invasive genomic tools.

A Shared Vision for Accessible Precision Medicine

"This partnership reflects a shared vision—making high-quality, science-driven genetic testing more widely available," said Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions. "We believe that technology should be inclusive. Working with AMPATH allows us to deliver advanced solutions through a familiar and trusted healthcare network."

Dr. Maneesh Bagai, COO of AMPATH shared: "We are thrilled to expand into next-generation sequencing through this strategic alliance. Together, we are redefining what's possible in diagnostics—whether it's in maternal health, early cancer detection, or personalized oncology with patient centric approach."

About AMPATH 

AMPATH (American Institute of Pathology and Laboratory Sciences) is a trusted leader in pathology services in India, known for its adherence to international standards and excellence in clinical diagnostics. Headquartered in Hyderabad, AMPATH operates a Central Reference Laboratory and a growing network of 20+ satellite labs across India, supported by NABL (National Accreditation Board for Testing & Calibration Laboratories) accreditation.

AMPATH is part of CTSI South Asia, which also operates the American Oncology Institute (AOI) and a network of specialty hospitals, reinforcing its commitment to outcome-focused, patient-centric healthcare. Through this integrated ecosystem, AMPATH plays a pivotal role in supporting precision medicine, early disease detection, and personalized treatment strategies across oncology and other specialties.

About Gene Solutions

Gene Solutions is a multinational biotechnology company at the forefront of genetic testing and research innovation across the Asia-Pacific region. Leveraging Next-Generation Sequencing (NGS) and Artificial Intelligence, the company offers a comprehensive portfolio that includes non-invasive prenatal testing (NIPT), cancer screening via circulating tumor DNA (ctDNA), genomic profiling, and treatment monitoring.

In addition to delivering over two million genetic tests, Gene Solutions is recognized for its proprietary research, CAP-accredited laboratories, and contributions to advancing precision medicine through clinical studies, technology development, and regional collaborations.

Explore more information at: https://genesolutions.com/

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

DUBAI, UAE, Jan. 15, 2026 /PRNewswire/ -- Mantle, the high-performance distribution and liquidity layer bridging traditional finance (TradFi), real-world assets (RWAs) and on-chain liquidity, today announced the integration of Infinex, a comprehensive cross-chain DeFi aggregation platform featuring a passkey-first wallet, unified portfolio management, and integrated trading capabilities.

The deployment of Infinex on Mantle significantly enhances access to Mantle-based assets and decentralized applications, offering users a streamlined, intuitive interface to discover liquidity, manage portfolios, and execute DeFi strategies seamlessly across multiple blockchain networks.

By expanding its presence on Infinex's marketplace, Mantle continues to advance its mission of making decentralized finance (DeFi) more accessible, efficient, and scalable, further empowering developers, traders, and liquidity providers with frictionless access to a growing on-chain ecosystem.

Why This Integration Matters 

Infinex aggregates liquidity from multiple protocols and simplifies advanced DeFi actions, including swaps, bridging, and yield opportunities all into a single, unified experience. This removes the need for users to navigate fragmented interfaces, making it easier to engage with Mantle-native assets and applications.

The integration strengthens Mantle's on-chain reach and interoperability, supporting broader ecosystem adoption as users increasingly seek seamless, cross-protocol access to DeFi services.

A Unified Trading Experience on Mantle

As Mantle continues to develop its modular Layer-2 ecosystem designed to unlock capital efficiency and institutional-grade utility for DeFi while making real-world finance flow seamlessly, integrations like Infinex delivers immediate, real-world value to users and partners alike.

Through Infinex, users can now discover, access, and deploy Mantle-native assets alongside a wide range of DeFi capabilities, including:

• Seamless Swaps: Executing token exchanges with optimized routing for the best available prices and minimal slippage.
• Integrated Bridging: Facilitating cross-chain asset transfers directly within the platform, removing the need for users to navigate separate, often confusing, bridging interfaces.
• Optimized Yield Opportunities: Presenting and automating access to various yield-generating strategies, including staking, lending, and liquidity provision, all from a single dashboard.

This unified experience lowers barriers to participation while enhancing liquidity flow and user engagement across Mantle's growing DeFi landscape.

Strategic Importance for Mantle's Ecosystem

The Infinex integration expands Mantle's visibility beyond its native ecosystem and facilitates deeper, more efficient liquidity flows across chains. As Mantle continues to attract a diverse range of DeFi builders, from decentralized exchanges and autonomous yield tools to AI-powered interfaces and RWA platforms, broader access through cross-chain aggregators plays a key role in driving on-chain activity, volume, and user adoption.

This milestone supports Mantle's long-term strategy to build a robust, accessible, and high-performance ecosystem that serves both sophisticated DeFi users and the next wave of mainstream participants.

About Mantle

Mantle positions itself as the premier distribution layer and gateway for institutions and TradFi to connect with on-chain liquidity and access real-world assets, powering how real-world finance flows.

With over $4B+ in community-owned assets, Mantle combines credibility, liquidity and scalability with institutional-grade infrastructure to support large-scale adoption. The ecosystem is anchored by $MNT within Bybit, and built out through core ecosystem projects like mETH, fBTC, MI4 and more. This is complemented by Mantle Network's partnerships with leading issuers and protocols such as Ethena USDe, Ondo USDY, OP-Succinct and EigenLayer.

For more information about Mantle, please visit: mantle.xyz

For more social updates, please follow: Mantle Official X & Mantle Community Channel

For media enquiries, please contact: contact@mantle.xyz 

About Infinex

Infinex is a crypto superapp that combines the best aspects of multichain wallets, DEX aggregation, perps trading, and much more. Through seamless UX, support for 20+ chains and passkey technology, Infinex provides the safest and easiest way to get onchain. Follow Infinex on X, and set up an account today at Infinex.xyz

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Mantle Expands Global DeFi Access through Infinex Integration